Øystein Førre

7.0k total citations
95 papers, 4.7k citations indexed

About

Øystein Førre is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Øystein Førre has authored 95 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 31 papers in Immunology and 28 papers in Hematology. Recurrent topics in Øystein Førre's work include Autoimmune and Inflammatory Disorders Research (26 papers), Systemic Lupus Erythematosus Research (18 papers) and Rheumatoid Arthritis Research and Therapies (18 papers). Øystein Førre is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (26 papers), Systemic Lupus Erythematosus Research (18 papers) and Rheumatoid Arthritis Research and Therapies (18 papers). Øystein Førre collaborates with scholars based in Norway, Croatia and India. Øystein Førre's co-authors include Berit Flatø, Margaretha Haugen, Jens Kjeldsen‐Kragh, Odd Vinje, Henning Værøy, Rafał Płoski, Erik Kåss, Anne Marit Mengshoel, Gunhild Lien and Lars Terenius and has published in prestigious journals such as The Lancet, The Journal of Immunology and PLoS ONE.

In The Last Decade

Øystein Førre

92 papers receiving 4.4k citations

Peers

Countries citing papers authored by Øystein Førre

Since Specialization

Citations

This map shows the geographic impact of Øystein Førre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein Førre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein Førre more than expected).

Fields of papers citing papers by Øystein Førre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øystein Førre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein Førre. The network helps show where Øystein Førre may publish in the future.

Co-authorship network of co-authors of Øystein Førre

This figure shows the co-authorship network connecting the top 25 collaborators of Øystein Førre. A scholar is included among the top collaborators of Øystein Førre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øystein Førre. Øystein Førre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study 2019 ·PLoS ONE ·(unknown), (unknown), Morten Wang Fagerland, Torstein Lyberg, Gunnbjørg Hjeltnes, Øystein Førre, Stefan Agewall, Tom Eirik Mollnes, Ivana Hollan	17
2	Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study 2010 ·Pediatric Rheumatology ·Gunhild Lien, Thor Ueland, Kristin Godang, Anne M. Selvaag, Øystein Førre, Berit Flatø	15
3	A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes 2008 ·Genes and Immunity ·Ngweina Francis Magitta, Anette S. B. Wolff, Stefan Johansson, Beate Skinningsrud, Benedicte A. Lie, K-M Myhr, Dag E. Undlien, Geir Joner, Pål R. Njølstad, Tore K Kvien, Øystein Førre, P.M. Knappskog, Eystein S. Husebye	144
4	Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis 2007 ·Human Immunology ·Marte K. Viken, (unknown), Geir Joner, Knut Dahl‐Jørgensen, Kjersti S. Rønningen, Dag E. Undlien, Berit Flatø, Anne M. Selvaag, Øystein Førre, Tore K Kvien, Erik Thorsby, Arthur Melms, Eva Tolosa, Benedicte A. Lie	28
5	Minor impact of juvenile arthritis on nutritional status in young adult patients 2002 ·Arthritis Care & Research ·Margaretha Haugen, Gunhild Lien, (unknown), (unknown), Odd Vinje, Dag Sørskaar, Øystein Førre	15
6	A gene in the telomeric HLA complex distinct from HLA–A is involved in predisposition to juvenile idiopathic arthritis 2002 ·Arthritis & Rheumatism ·A Smerdel, Benedicte A. Lie, Rafał Płoski, Bobby P. C. Koeleman, Øystein Førre, Erik Thorsby, Dag E. Undlien	19
7	Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation 1999 ·Lara D. Veeken ·David A. Fraser, J. Thöen, Arild C. Rustan, Øystein Førre, Jens Kjeldsen‐Kragh	39
8	A 5.5 Year Prospective Study of Self-Reported Musculoskeletal Pain and of Fibromyalgia in a Female Population: Significance and Natural History 1999 ·Clinical Rheumatology ·Karin Øien Forseth, Øystein Førre, Jan Tore Gran	68
9	Decreased CD4+ Lymphocyte Activation and Increased Interleukin-4 Production in Peripheral Blood of Rheumatoid Arthritis Patients After Acute Starvation 1999 ·Clinical Rheumatology ·David A. Fraser, J. Thöen, Janne E. Reseland, Øystein Førre, Jens Kjeldsen‐Kragh	114
10	Measuring disability in early juvenile rheumatoid arthritis: evaluation of a Norwegian version of the childhood Health Assessment Questionnaire. 1998 ·PubMed ·Berit Flatø, Dag Sørskaar, Odd Vinje, Gunhild Lien, Astrid Aasland, Torbjørn Moum, Øystein Førre	29
11	Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold 1998 ·Lara D. Veeken ·H. Zeidler, T.K. Kvien, Pekka Hannonen, Frank A. Wollheim, Øystein Førre, (unknown), (unknown), (unknown), Marjatta Leirisalo‐Repo, B. Manger, Leena Laasonen, Eva Markert, H. Prestele, Pekka Kurki	51
12	Toxicity of antirheumatic and anti-inflammatory drugs in children 1998 ·Clinical Rheumatology ·Berit Flatø, Odd Vinje, Øystein Førre	16
13	Interaction between HLA-DR and HLA-DP, and Between HLA and interleukin 1α in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease 1995 ·Human Immunology ·Rafał Płoski, Tarra L. McDowell, Julian Symons, Berit Flatø, (unknown), Erik Thorsby, Øystein Førre	16
14	Changes in plasma phospholipid fatty acids and their relationship to disease activity in rheumatoid arthritis patients treated with a vegetarian diet 1994 ·British Journal Of Nutrition ·Margaretha Haugen, Jens Kjeldsen‐Kragh, (unknown), Arne T. Høstmark, Øystein Førre	23
15	Hla class ii alleles and heterogeneity of juvenile rheumatoid arthritis. drb10101* may define a novel subset of the disease 1993 ·Arthritis & Rheumatism ·Rafał Płoski, Odd Vinje, Kjersti S. Rønningen, Anne Spurkland, Dag Sørskaar, Frode Vartdal, Øystein Førre	60
16	Pain and fatigue in patients with rheumatic disorders 1993 ·Clinical Rheumatology ·Anne Marit Mengshoel, Øystein Førre	46
17	The influence of fast and vegetarian diet on parameters of nutritional status in patients with rheumatoid arthritis 1993 ·Clinical Rheumatology ·Margaretha Haugen, Jens Kjeldsen‐Kragh, Niels E. Skakkebæk, Sverre Landaas, Ø. V. Sjaastad, (unknown), Øystein Førre	20
18	Diet and disease symptoms in rheumatic diseases — Results of a questionnaire based survey 1991 ·Clinical Rheumatology ·Margaretha Haugen, Jens Kjeldsen‐Kragh, Bjørn Yngvar Nordvåg, Øystein Førre	63
19	Treatment of fibromyalgia (Fibrositis syndrome): A parallel double blind trial with carisoprodol, paracetamol and caffeïne (Somadril comp®) versus placebo 1989 ·Clinical Rheumatology ·Henning Værøy, A. M. Abrahamsen, Øystein Førre, Erik Kåss	40
20	Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis 1988 ·Pain ·Henning Værøy, (unknown), Øystein Førre, Erik Kåss, Lars Terenius	335

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact